De Lisle Partners LLP acquired a new position in Vital Farms, Inc. (NASDAQ:VITL - Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 152,771 shares of the company's stock, valued at approximately $1,774,000. De Lisle Partners LLP owned 0.36% of Vital Farms at the end of the most recent reporting period.
Several other institutional investors have also recently made changes to their positions in VITL. Advisors Asset Management Inc. lifted its position in Vital Farms by 1.4% during the fourth quarter. Advisors Asset Management Inc. now owns 34,072 shares of the company's stock valued at $1,088,000 after purchasing an additional 479 shares during the period. Van ECK Associates Corp raised its stake in shares of Vital Farms by 7.7% during the 4th quarter. Van ECK Associates Corp now owns 6,912 shares of the company's stock valued at $221,000 after buying an additional 495 shares during the last quarter. Caitong International Asset Management Co. Ltd raised its stake in shares of Vital Farms by 47.4% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 1,957 shares of the company's stock valued at $63,000 after buying an additional 629 shares during the last quarter. HighTower Advisors LLC lifted its holdings in shares of Vital Farms by 2.2% in the 4th quarter. HighTower Advisors LLC now owns 35,631 shares of the company's stock valued at $1,138,000 after buying an additional 754 shares during the period. Finally, Triumph Capital Management acquired a new position in shares of Vital Farms in the 4th quarter valued at about $25,000. Hedge funds and other institutional investors own 98.59% of the company's stock.
Wall Street Analyst Weigh In
Several research firms recently commented on VITL. Morgan Stanley set a $10.00 target price on Vital Farms in a report on Friday, May 8th. Mizuho set a $20.00 price target on Vital Farms in a report on Monday, May 4th. BMO Capital Markets restated an "outperform" rating and issued a $15.00 price objective on shares of Vital Farms in a research report on Friday, August 7th. TD Cowen raised their price objective on shares of Vital Farms from $10.00 to $11.00 and gave the stock a "hold" rating in a research note on Friday, August 7th. Finally, Benchmark raised shares of Vital Farms from a "hold" rating to a "buy" rating in a report on Thursday, August 6th. Five equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $17.18.
Check Out Our Latest Report on VITL
Vital Farms Price Performance
Shares of Vital Farms stock opened at $10.57 on Friday. The company has a quick ratio of 0.60, a current ratio of 1.10 and a debt-to-equity ratio of 0.11. Vital Farms, Inc. has a twelve month low of $7.95 and a twelve month high of $53.13. The business has a 50-day moving average price of $12.05 and a 200 day moving average price of $14.39. The firm has a market cap of $453.77 million, a PE ratio of -264.25 and a beta of 1.07.
Vital Farms (NASDAQ:VITL - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported ($0.47) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.47). The company had revenue of $166.03 million during the quarter, compared to analysts' expectations of $160.24 million. Vital Farms had a return on equity of 3.46% and a net margin of 0.02%.Vital Farms's quarterly revenue was down 10.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.36 EPS. Sell-side analysts predict that Vital Farms, Inc. will post -0.48 earnings per share for the current fiscal year.
Vital Farms Profile
(
Free Report)
Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms' supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.
Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.